What are the clinical guidelines for using ketamine in infants and toddlers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Guidelines for Ketamine Use in Infants and Toddlers

Ketamine is recommended for procedural sedation in infants and toddlers with atropine premedication, particularly for intubation and invasive procedures in septic shock, as it maintains cardiovascular stability while providing effective sedation and analgesia. 1

Dosing Guidelines

Intravenous (IV) Administration

  • Initial dose: 1-1.5 mg/kg IV 2
  • Supplemental dosing: 0.25-0.5 mg/kg as needed 2
  • Age-specific considerations:
    • 2-year-olds: 2.125 mg/kg 3
    • 6-year-olds: 2 mg/kg 3
    • 12-year-olds: 1.75 mg/kg 3

Intramuscular (IM) Administration

  • Initial dose: 3-4 mg/kg IM 2, 4
  • Optimal dose range: 4-5 mg/kg IM (provides adequate sedation in 93-100% of children) 4
  • Onset of action: 3-5 minutes 2
  • Duration of action: 15-30 minutes 2

Indications

  1. Procedural sedation for:

    • Orthopedic procedures 1
    • Wound management 1
    • Laceration repair 1
    • Burn care 1
    • Lumbar puncture 1
  2. Intubation and invasive procedures in septic shock 1

    • Maintains cardiovascular stability through:
      • Blocking nuclear factor-kappa B transcription
      • Reducing systemic interleukin-6 production
      • Maintaining intact adrenal axis 1

Monitoring Requirements

  • Continuous pulse oximetry
  • Heart rate and blood pressure monitoring every 5 minutes
  • Close observation of respiratory status and level of consciousness 2
  • Consider capnography for early detection of hypoventilation 2
  • For moderate to deep sedation: continuous capnography and ECG 2

Safety Profile

Advantages

  • Maintains cardiovascular stability 1
  • High efficacy rate (approaching 100% in clinical studies) 1, 2
  • Rapid onset of action 2
  • Low rate of significant adverse events without serious sequelae 1

Adverse Effects

  • Respiratory events:

    • Hypoxemia (SpO₂ <90%): approximately 1.6% with ketamine alone 2
    • Laryngospasm: 0.9-1.4% in general ED settings 1
    • Higher risk (8.2%) in children undergoing gastrointestinal procedures, particularly in children <6 years (13.9%) 1
  • Other common adverse effects:

    • Emesis: 7-14% of cases 2
    • Recovery agitation: more common in younger children 2
    • Ataxia during recovery: 7% of cases 2
    • Tachycardia 2

Special Considerations for Infants and Toddlers

  1. Dosing considerations:

    • Younger children require higher weight-based dosing 3, 5
    • Careful titration is essential 2
  2. Safety concerns:

    • FDA notes that safety and effectiveness have not been established in patients below 16 years of age 6
    • Animal studies suggest potential neuroapoptosis with NMDA receptor antagonists during rapid brain development 6, 7
    • The window of vulnerability may extend from third trimester through first several months of life 6
  3. Adjunctive medications:

    • Atropine: Recommended as premedication (0.02 mg/kg) to reduce secretions 1, 8
    • Midazolam: Often used in combination (0.05-0.1 mg/kg IV) 2
      • Does not decrease recovery agitation 1
      • May decrease incidence of emesis 1
      • Increases risk of respiratory depression when combined 2
      • Doses above 0.3 mg/kg should be used with caution due to risk of desaturation 5

Recovery and Discharge

  • Recovery time:

    • IV ketamine: 65-85 minutes 2
    • IM ketamine: approximately 90 minutes (range 60-130 minutes) 2, 8
  • Discharge criteria:

    • Return to baseline consciousness
    • Stable vital signs
    • Ability to maintain airway independently 2

Important Caveats and Pitfalls

  1. Avoid etomidate in pediatric septic shock as it's associated with increased mortality due to inhibition of adrenal corticosteroid biosynthesis 1

  2. Limited data in neonates: Little has been published on ketamine use in newborns with shock, so no firm recommendations can be made for this specific age group 1

  3. Risk of respiratory depression: Higher when combined with other sedatives or opioids 2

  4. Developmental concerns: Animal studies suggest potential neurotoxicity during periods of rapid brain development 6, 7

  5. Contraindications:

    • History of airway instability
    • Active pulmonary infection or disease
    • Increased intracranial pressure
    • Psychosis

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sedation Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What is the optimal dose of intramuscular ketamine for pediatric sedation?

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 1999

Research

Use of midazolam and ketamine as sedation for children undergoing minor operative procedures.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005

Research

Ketamine: a controversial drug for neonates.

Seminars in perinatology, 2007

Research

Ketamine sedation for children in the emergency department.

Emergency medicine (Fremantle, W.A.), 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.